https://www.live-feeds.com/feed/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity-drugContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity-drughttps://www.live-feeds.com/feed/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity-drug#u21494Thu, 02 Jul 2026 15:01:48 +0000The White House has rejected claims that President Donald Trump is the 79-year-old man granted access to Eli Lilly's retatrutide. The speculation followed a STAT News report on the drug's exclusive use. Fact checkers have labeled the claims as mostly false.What's confirmed:The White House denied claims that Donald Trump received exclusive access to the experimental obesity drug.Eli Lilly and the FDA granted a 79-year-old man access to retatrutide following an April request.STAT News published an investigation on June 23, 2026, regarding the drug.Still unconfirmed:Donald Trump is the https://www.live-feeds.com/feed/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity-drughttps://www.live-feeds.com/feed/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity-drug#u15431Sat, 27 Jun 2026 06:56:07 +0000Eli Lilly provided a single 79-year-old patient with access to the unapproved obesity drug retatrutide through a compassionate use program. Public speculation has linked the patient to Donald Trump. The White House has dismissed these claims as baseless speculation.What's confirmed:Eli Lilly provided a 79-year-old patient with access to the experimental obesity drug retatrutide via a compassionate use program.The drug retatrutide has not been approved by the FDA.The White House denied that Donald Trump was the recipient of the drug.Still unconfirmed:Donald Trump used his office to obtain the p